Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-29 @ 6:25 AM
Study NCT ID:
NCT05668403
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2022-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Sponsor:
Shanghai Jiaolian Drug Research and Development Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-12
First Submit QC Date:
None
Study First Post Date:
2022-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-07
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL